ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process
- PMID: 36406781
- PMCID: PMC9667481
- DOI: 10.3389/ti.2022.10915
ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process
Abstract
The European Society for Organ Transplantation (ESOT) has created a platform for the development of rigorous and regularly updated evidence based guidelines for clinical practice in the transplantation field. A dedicated Guideline Taskforce, including ESOT-council members, a representative from the Centre for Evidence in Transplantation, editors of the journal Transplant International has developed transparent procedures to guide the development of guidelines, recommendations, and consensus statements. During ESOT's first Consensus Conference in November 2022, leading experts will present in-depth evidence based reviews of nine themes and will propose recommendations aimed at reaching a consensus after public discussion and assessment by an independent jury. All recommendations and consensus statements produced for the nine selected topics will be published including the entire evidence-based consensus-finding process. An extensive literature review of each topic was conducted to provide final evidence and/or expert opinion.
Keywords: consensus conference; guidelines; methodology; organ transplantation; platform.
Copyright © 2022 Cillo, Weissenbacher, Pengel, Jochmans, Roppolo, Amarelli, Belli, Berenguer, De Vries, Ferrer, Friedewald, Furian, Greenwood, Monbaliu, Nadalin, Neyrinck, Strazzabosco, Toso, Zaza, Thuraisingham, Berney, Potena, Montserrat and Selzner.
Conflict of interest statement
IJ received speaker fees from XVIVO perfusion paid to her institution. IJ is an ESOT Councilor for which she receives no reimbursement. JFe is recipient of a grant supported by Instituto de Salud Carlos III (ISCIII) through the project “PI18/00161 (Optimization of pancreas transplant graft: A multicentric study of histo-morphological and functional characteristics of unaccepted organs.)” and co-funded by the European Union. AdV received in the past speaker and consultation fees from Astellas, Chiesi, Hansa, Novartis, Sandoz, CSL Behring all of which paid to his institution. AdV is chair of the Dutch Kidney Advisory Committee (Landelijk Overleg NierTransplantatie LONT) for which he receives no reimbursement. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Equity, Diversity and Inclusion (EDI) in Organ Transplantation: An ESOT Survey About EDI Within ESOT as an Organization and its Educational Activities, and Transplantation Research and Science.Transpl Int. 2023 Aug 23;36:11331. doi: 10.3389/ti.2023.11331. eCollection 2023. Transpl Int. 2023. PMID: 37680646 Free PMC article.
-
European Society of Organ Transplantation (ESOT) Consensus Statement on Prehabilitation for Solid Organ Transplantation Candidates.Transpl Int. 2023 Jul 21;36:11564. doi: 10.3389/ti.2023.11564. eCollection 2023. Transpl Int. 2023. PMID: 37547750 Free PMC article. Review.
-
The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.Pediatrics. 2006 May;117(5):e955-77. doi: 10.1542/peds.2006-0206. Epub 2006 Apr 17. Pediatrics. 2006. PMID: 16618790
-
European Society for Organ Transplantation (ESOT)-TLJ 3.0 Consensus on Histopathological Analysis of Pre-Implantation Donor Kidney Biopsy: Redefining the Role in the Process of Graft Assessment.Transpl Int. 2023 Jul 4;36:11410. doi: 10.3389/ti.2023.11410. eCollection 2023. Transpl Int. 2023. PMID: 37470063 Free PMC article.
-
Methodology: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.Chest. 2014 Oct;146(4 Suppl):35S-41S. doi: 10.1378/chest.14-0746. Chest. 2014. PMID: 25144246 Review.
Cited by
-
Biomarkers are strongly needed in liver transplantation, time to move forward.Hepatobiliary Surg Nutr. 2024 Apr 3;13(2):359-361. doi: 10.21037/hbsn-24-31. Epub 2024 Mar 27. Hepatobiliary Surg Nutr. 2024. PMID: 38617484 Free PMC article. No abstract available.
-
European Society for Organ Transplantation (ESOT) Consensus Statement on the Role of Pancreas Machine Perfusion to Increase the Donor Pool for Beta Cell Replacement Therapy.Transpl Int. 2023 Jul 19;36:11374. doi: 10.3389/ti.2023.11374. eCollection 2023. Transpl Int. 2023. PMID: 37547751 Free PMC article.
-
European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma.Transpl Int. 2023 Sep 14;36:11648. doi: 10.3389/ti.2023.11648. eCollection 2023. Transpl Int. 2023. PMID: 37779513 Free PMC article.
-
European Society for Organ Transplantation (ESOT) Consensus Statement on the Use of Non-invasive Biomarkers for Cardiothoracic Transplant Rejection Surveillance.Transpl Int. 2024 Jun 11;37:12445. doi: 10.3389/ti.2024.12445. eCollection 2024. Transpl Int. 2024. PMID: 38962472 Free PMC article. Review.
-
Embracing the Wisdom of Ancient Greece in the Era of Personalized Medicine-Uncertainty, Probabilistic Reasoning, and Democratic Consensus.Transpl Int. 2023 Oct 26;36:12178. doi: 10.3389/ti.2023.12178. eCollection 2023. Transpl Int. 2023. PMID: 37954528 Free PMC article.
References
-
- Institute of Medicine (US) Committee to Improve the National Institutes of Health Consensus Development Program. Consensus Development at the NIH: Improving the Program. Washington (DC): National Academies Press US; (1990). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical